Related Experiment Video

Updated: Mar 26, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.8K

The Prominent Role of Protein-Based Delivery Systems on the Development of Cancer Treatment

Hasan Kouchakzadeh, Seyed Abbas Shojaosadati1

  • 1Biotechnology Group, Chemical Engineering Faculty, TarbiatModares University, Tehran, Iran. shoja_sa@modares.ac.ir.

Current Pharmaceutical Design
|February 5, 2016
PubMed

Insights

Protein-based nanoparticles offer promising advancements in cancer drug delivery. These systems show potential for improved cancer treatment due to their biocompatibility and high therapeutic loading capacity.

Area of Science:

  • Oncology
  • Nanotechnology
  • Drug Delivery

Background:

  • Nanotherapeutics present significant opportunities for cancer drug and gene delivery.
  • The commercialization of nanoparticulate oncology drugs involves risks but holds considerable promise.
  • Clinical trials are increasingly incorporating nanoparticle delivery systems for cancer treatment.

Purpose of the Study:

  • To provide a comprehensive overview of protein-based nanoparticles for anticancer agent delivery.
  • To interpret the challenges encountered in the field of protein-based nanoparticle drug delivery.
  • To highlight the recent findings in utilizing protein-based nanoparticles for cancer therapy.

Main Methods:

  • Review of recent scientific literature on protein-based nanoparticles in cancer therapy.
  • Analysis of the properties and applications of protein-based nanoparticles.
  • Interpretation of challenges and opportunities in the field.

Main Results:

  • Protein-based nanoparticles are pioneers in successful nanoparticulate systems for cancer treatment.
  • These systems exhibit functionalization, biocompatibility, non-immunogenicity, and high loading capacity.
  • Several protein-based nanoparticle products are approved or under development.

Conclusions:

  • Protein-based nanoparticles are a leading nanoparticulate system for enhancing cancer treatment.
  • Their inherent properties make them highly suitable for delivering anticancer agents.
  • Continued research and development are crucial for overcoming challenges in clinical translation.

More Related Videos

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.7K
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

10.2K

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
94
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
107
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
214
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
112